BioSpace News Archive

CANNAMERICA BRANDS CORP. (“CannAmerica” or the “Company”) (CSE: CANA) (OTCQB: CNNXF) has granted an aggregate of 2,450,000 incentive stock options to purchase common shares to certain officers, directors, and other eligible persons of the Company.

Solidarity HealthShare, a pro-life health sharing ministry and major sponsor of the 2019 March For Life honors Dr. George Delgado, M.D., with the Solidarity HealthShare’s Pro-Life Innovator Award.

Illumina today announced that it will issue results for fourth quarter and fiscal year 2018 following the close of market on Tuesday, January 29, 2019.

Five Prime Therapeutics, Inc. (NASDAQ: FPRX), a clinical-stage biotechnology company focused on discovering and developing innovative immuno-oncology protein therapeutics, announced today a corporate restructuring to focus resources on its development pipeline, comprising five clinical-stage cancer programs in various solid tumor types and addressing multiple cell types in the tumor microenvironment.

Almac Clinical Services is delighted to invite participants from the Biopharma Industry to join its upcoming Workshop on Thursday 31st January.

Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical stage targeted oncology company, announced today that it has dosed the first patient in a Phase 1/2 clinical trial of MRTX849, an investigational KRAS G12C inhibitor for patients with advanced solid tumors that harbor KRAS G12C mutations.

Today, Executive Insight celebrates the culmination of our partnership with One Family Health in Rwanda. For two years, Executive Insight has been supporting One Family Health (OFH) in its mission to make primary care more accessible to underserved communities.

Getting access to high-quality health care can often be a challenge for many patients, but it’s not always impossible.

- Test scans images of cells to pick out clusters with misshapen nuclei - Ovarian cancers detected by test are especially aggressive – but might also be susceptible to targeted treatment - These cancers evade immune system through brand new mechanism that could be target of future immunotherapies

MilliporeSigma today announced that it has been recognized by BioInformatics LLCwith a 2018 Life Science Industry Award® for best use of social media.